INDSWIFT LABORATORIES
Back to Income Statement
|
INDSWIFT LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹421 Cr | ₹48 Cr | ₹-2.15 Cr | ₹-3.15 Cr | ₹-21 Cr |
What is the latest Consolidated Net Profit of INDSWIFT LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹421 Cr |
Mar2023 | ₹48 Cr |
Mar2022 | ₹-2.15 Cr |
Mar2021 | ₹-3.15 Cr |
Mar2020 | ₹-21 Cr |
How is Consolidated Net Profit of INDSWIFT LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹421 Cr | 784.43 | |
Mar2023 | ₹48 Cr | Positive | |
Mar2022 | ₹-2.15 Cr | Negative | |
Mar2021 | ₹-3.15 Cr | Negative | |
Mar2020 | ₹-21 Cr | - |
Compare Consolidated Net Profit of peers of INDSWIFT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDSWIFT LABORATORIES | ₹717.4 Cr | 1.2% | 3.1% | -21.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
INDSWIFT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | 1.2% |
3.1% |
-21.3% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses